Key Takeaways
- ARM shares declined 8% but maintain approximately 80% gains year-to-date
- Fiscal Q4 2026 results due May 6; Wall Street projects $0.58 EPS and $1.47B in revenue
- Wells Fargo increased price target to $220 while maintaining Overweight stance
- Forward guidance expected to be the primary catalyst for stock movement
- Analyst consensus rates ARM a Strong Buy with $183.71 average price target
Shares of ARM experienced a significant pullback Wednesday, tumbling 8% to begin trading at $198.65. Even with this retreat, the stock maintains impressive year-to-date gains of approximately 80%, underscoring the substantial AI-related enthusiasm embedded in its valuation.
Arm Holdings plc American Depositary Shares, ARM
This decline arrives just ahead of the company’s fiscal fourth quarter 2026 earnings announcement, scheduled for after market hours on May 6.
Wall Street consensus calls for earnings of $0.58 per share alongside revenue of $1.47 billion for the quarter. This projection indicates sequential growth from the previous quarter, when ARM surpassed expectations with $0.43 EPS on $1.24 billion in revenue — marking a 26.3% year-over-year increase.
Wells Fargo elevated its price target to $220 from $175 this week while reaffirming an Overweight rating. The firm highlighted ARM’s advantageous position in AI-powered data center markets, where appetite for energy-efficient chip designs continues expanding.
However, Wells Fargo acknowledged the challenging near-term dynamics. Following the stock’s substantial run, expectations are elevated. The firm characterized Q4 as presenting a “tougher setup given recent move,” anticipating management will likely confirm its 2027 revenue growth projection of approximately 20% year-over-year.
Critical Factors for the May 6 Report
Forward-looking guidance will carry more weight than historical performance. Market participants are focused on updates regarding AI demand patterns, data center growth trajectory, and royalty revenue trends — the fundamental drivers of ARM’s business model.
Should management boost its outlook, the stock could recover swiftly. Conversely, if guidance merely reconfirms existing projections, the recent decline may extend further.
With a P/E ratio of 264.87, the stock offers minimal margin for error. This dynamic creates considerable tension heading into the earnings release.
Regarding insider activity, CFO Jason Child divested 21,280 shares in late March at approximately $148.37, while CEO Rene Haas sold 23,867 shares at $161.17. Combined insider sales total 83,712 shares valued at roughly $13.6 million over the past three months.
Institutional ownership currently represents 7.53% of shares outstanding, with multiple smaller investment firms establishing new positions in recent quarters.
Wall Street’s View
Analyst sentiment remains predominantly bullish. Among 24 analysts tracking the stock, 19 assign it a Buy rating, four recommend Hold, and one rates it Sell. The consensus price target stands at $183.71 — suggesting approximately 7.5% downside from Wednesday’s opening price.
This divergence between the consensus target and current trading level deserves attention. Despite the Strong Buy rating, the average analyst forecast suggests limited near-term appreciation potential.
HSBC executed one of the most notable rating changes recently, upgrading ARM from Reduce to Buy while raising its target from $90 to $205 in March. Meanwhile, JPMorgan, Evercore, and UBS all reduced their targets in February following the previous earnings announcement.
ARM’s 52-week trading range spans from $100.02 to $237.68, with the stock currently positioned well above both its 50-day moving average of $145.44 and 200-day moving average of $136.84.
The earnings conference call is scheduled for 5:00 PM ET on May 6.





